Evidence map›Paper›PMID 31725750›Full record

ArticlePloS one2019

Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort study.

Catrina Mugglin, Andreas D Haas, Joep J van Oosterhout, Malango Msukwa, Lyson Tenthani, Janne Estill, Matthias Egger, Olivia Keiser

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Catrina MugglinInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0001-7966-3939
Andreas D HaasInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Joep J van OosterhoutDignitas International, Zomba, Malawi.
Malango MsukwaBaobab Health Trust, Lilongwe, Malawi.
Lyson TenthaniInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Janne EstillInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Matthias EggerInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0001-7462-5132
Olivia KeiserInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

objectivesWe examine long-term retention of adults, adolescents and children on antiretroviral therapy under different HIV treatment guidelines in Malawi.

designProspective cohort study. SETTING AND

participantsAdults and children starting ART between 2005 and 2015 in 21 health facilities in southern Malawi.

methodsWe used survival analysis to assess retention at clinic level, Cox regression to examine risk factors for loss to follow up, and competing risk analysis to assess long-term outcomes of people on antiretroviral therapy (ART).

resultsWe included 132,274 individuals in our analysis, totalling 270,256 person years of follow up (PYFU; median per patient 1.3, interquartile range (IQR) 0.26-3.1), 62% were female and the median age was 32 years. Retention on ART was lower in the first year on ART compared to subsequent years for all guideline periods and age groups. Infants (0-3 years), adolescents and young adults (15-24 years) were at highest risk of LTFU. Comparing the different calendar periods of ART initiation we found that retention improved initially, but remained stable thereafter.

conclusionEven though the number of patients and the burden on health care system increased substantially during the study period of rapid ART expansion, retention on ART improved in the early years of ART provision, but gains in retention were not maintained over 5 years on ART. Reducing high attrition in the first year of ART should remain a priority for ART programs, and so should addressing poor retention among adolescents, young adults and men.

Indexed as

Antiretroviral Therapy, Highly ActiveAdolescentAdultChildCohort StudiesFemaleHIV InfectionsHumansInfantInfant, NewbornMalawiMaleProportional Hazards ModelsRisk FactorsTime FactorsTreatment Outcome

Identifiers

PMID31725750
PMCPMC6855432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.